GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>I think you are missing his point, which I take to be that the market cap reflects a lack of insight--because most owners lack both the industry and the information to obtain it--whereas a suitor would have made a more thorough study of the matter, being better resourced and more highly motivated to weigh our prospects with sober care and in detail.<

Exactly right.


Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”